Delivery Order SPE2DB20D3103-SPE2DB25FQ2K6
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $18,577.92, with an ultimate completion date of August 15, 2025. The contract is non-set-aside and represents a competitive award under the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $36,293.07. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $5,898.82 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract was awarded to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, which serves as the place of performance, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $6,378.11 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded pharmaceutical procurement. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery...
- The Defense Logistics Agency awarded a $22,405.18 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $39,247.54 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 10, 2025, with performance to take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,718.58 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) on September 4, 2025, with completion scheduled for September 5, 2025. This competitive award, issued without set-aside designation, reflects a firm fixed-price delivery order structure under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract is valued at $59,442.23 and carries a firm fixed price structure with completion scheduled for September 11, 2025. The delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $17,009.72. This delivery order, which is competitively awarded with no set-aside designation, represents a firm fixed-price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,096.32 and is scheduled for completion by August 1, 2025. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2K6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $220,407.12. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's medical supply chain operations, which provide critical medications and medical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a prime vendor for federal medical procurement, supplying an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $220.4k | 9/10/25 |